Projects
Vaccine & Infectious Diseases Excellence in Antwerp: Infectious disease prevention, control and management in a One Health policy context (VAX-IDEA). University of Antwerp
Innovative approaches to tackle autoimmune diseases: immune-mediated thrombotic thrombocytopenic purpura as a disease model KU Leuven
Obstructive lung diseases: structural heterogeneity and innate immune tasks for sustained disease modification. KU Leuven
RESTOREID. Restoring Ecosystems to Stop the Threat Of (Re-)Emerging Infectious Diseases. University of Antwerp
Inter-organelle communication through membrane contact sites in oncology and neurodegenerative diseases (InterAction) KU Leuven
INFLA-MED - Fundamental research in the pathophysiological processes of inflammatory diseases. University of Antwerp
Building towards a patent - Exploitation of the killifish R&D platform to combat neurodegenerative diseases KU Leuven
New intranasal marker vector vaccine for protection of horses against equine herpesvirus 1 related and other (re)emerging viral diseases. Ghent University
This project aims to develop a live attenuated vaccine to protect horses against equine herpesvirus 1 (EHV-1)-associated diseases by intranasal administration. This vaccine will protect the upper respiratory tract (primary replication site of EHV-1) of horses by the activation of a local and general immunity. The proposed vaccine strain will have a plugin spot for the introduction of other foreign (viral) genes, which allows to use this ...
Nature-based solutions to control malaria and aquatic snail-borne diseases in Ethiopia Ghent University
Malaria and Snail-borne diseases are parasitic diseases that cause significant health and socio-economic impact around the world. They are most prevalent tropical diseases and a leading cause of morbidity. Previous vector-borne disease control approaches shown several limitations. This research will investigate the potential of nature-based solutions to control the vectors. The outcomes will be used to support policy makers.